These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5309480)

  • 21. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Live influenza vaccines (author's transl)].
    Gerth HJ
    MMW Munch Med Wochenschr; 1977 Jun; 119(24):821-4. PubMed ID: 407467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Live influenza virus vaccine].
    Shimizu K; Oguro M; Mukaigawa J
    Uirusu; 1984 Jun; 34(1):25-36. PubMed ID: 6382793
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
    Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some studies on the selection and efficiency of live influenza vaccine viruses.
    Tyrrell DA; Beare AS
    Bull World Health Organ; 1969; 41(3):581-4. PubMed ID: 5309479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies with live attenuated influenza vaccines.
    Douglas RG; Betts RF
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):153-8. PubMed ID: 685888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of live attenuated influenza virus vaccine in the US.
    Belshe RB
    Virus Res; 2004 Jul; 103(1-2):177-85. PubMed ID: 15163507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.
    Ghendon YZ
    Bull World Health Organ; 1984; 62(3):493-9. PubMed ID: 6331910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of live attenuated influenza vaccine ts-1(E) in man.
    Gwaltney JM
    Dev Biol Stand; 1976; 33():178-83. PubMed ID: 782966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of influenza virus mutants for possible use in a live virus vaccine.
    Mills J; Van Kirk J; Hill DA; Chanock RM
    Bull World Health Organ; 1969; 41(3):599-606. PubMed ID: 5309483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effectiveness of live influenza vaccines obtained by strain recombination and passages].
    Zhilova GP; Orlov VA; Malikova EV; Kozhukhov VM
    Vopr Virusol; 1987; 32(6):675-81. PubMed ID: 3445585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of protection provided by live attenuated influenza vaccine in children.
    Ambrose CS; Yi T; Walker RE; Connor EM
    Pediatr Infect Dis J; 2008 Aug; 27(8):744-8. PubMed ID: 18600188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing the safety and effectiveness of oral administration of a live influenza vaccine.
    Aleksandrova GI; Smorodintsev AA; Beljaeva NM; Vasil'ev BJ; Geft RA; Panteleev VG; Sejfer MA; Selivanov AA
    Bull World Health Organ; 1970; 42(3):429-36. PubMed ID: 5310592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EXPERIENCES IN THE DEVELOPMENT OF LIVE VACCINES AGAINST INFLUENZA AND INFLUENZA-LIKE RESPIRATORY INFECTIONS.
    SMORODINTSEN AA; ALEXANDROVA GA; CHALKOVA OU; SELIVANOV AA
    Ind Med Surg; 1965 Jan; 34():53-64. PubMed ID: 14267214
    [No Abstract]   [Full Text] [Related]  

  • 40. Live tissue-culture influenza vaccine.
    RITOVA VV; EVSTIGNEEVA NA
    Bull World Health Organ; 1962; 27(6):729-34. PubMed ID: 13974075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.